BCB Bancorp (BCBP) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
6 Aug, 2025Executive summary
Total assets decreased 6.1% to $3.38 billion at June 30, 2025, mainly due to lower net loans and cash balances.
Net loss of $4.8 million for the first half of 2025, with Q2 net income of $3.6 million reversing an $8.3 million Q1 loss.
Allowance for credit losses increased to $50.7 million, or 1.74% of gross loans, reflecting higher provisioning, especially for cannabis and Business Express portfolios.
Deposits declined 3.2% to $2.66 billion, with brokered and transaction accounts down, partially offset by increases in other deposit categories.
Stockholders' equity fell 2.5% to $315.7 million, mainly due to the Q1 loss and lower retained earnings.
Financial highlights
Net interest margin rose to 2.80% in Q2 2025 from 2.60% in Q2 2024, with net interest income for Q2 at $23.1 million, down year-over-year.
Interest income fell 12.7% to $43.2 million for Q2 2025; interest expense decreased by $5.7 million.
Non-interest income rose by $5.3 million to $2.1 million in Q2 2025, mainly due to the absence of prior year loan sale losses.
Non-interest expense increased 9.2% to $15.3 million in Q2 2025, driven by higher salaries and data processing costs.
Provision for credit losses was $25.7 million for the first half of 2025, with $4.9 million in Q2, down from $20.8 million in Q1.
Outlook and guidance
Management expects medium- to long-term profitability to improve as asset quality challenges are addressed.
Aggressive provisioning and credit actions have depressed short-term results but are expected to support future stability.
The cannabis loan portfolio, at $103 million, poses increased credit risk and may require further reserves if industry challenges persist.
The company expects to have sufficient liquidity and funding to meet commitments through typical sources.
Latest events from BCB Bancorp
- Q4 2025 net loss of $12M due to REO write-down and C&I charge-offs; dividend cut to $0.08.BCBP
Q4 202530 Jan 2026 - Annual meeting to vote on directors, auditor, and executive pay, with strong governance focus.BCBP
Proxy Filing2 Dec 2025 - Net income rose sequentially, but higher credit losses and expenses pressured results.BCBP
Q3 20255 Nov 2025 - Net income held steady, but credit quality and margins faced ongoing pressure.BCBP
Q3 202413 Jun 2025 - Q2 net income fell on loan sale losses, but capital and liquidity remain strong.BCBP
Q2 202413 Jun 2025 - Q1 2025 net loss of $8.3M driven by credit loss surge; dividend held at $0.16 per share.BCBP
Q1 20256 Jun 2025 - Earnings declined sharply in Q4 2024 as credit costs rose and asset quality deteriorated.BCBP
Q4 20245 Jun 2025